ARTICLE | Company News
Introgen board of directors update
August 18, 2008 7:00 AM UTC
Introgen Therapeutics Inc. (NASDAQ:INGN), Austin, Texas Business: Gene/Cell therapy, Cancer Appointed: James Rothman, Wallace professor of biomedical sciences, chairman of the department of cell biolo...